the infectious disease diagnostic market is projected to reach $39.94 billion by 2030, growing at a CAGR of 6.8% from 2021 to 2030.

While all poly ADP-ribose polymerase (PARP) inhibitors improved progression-free survival, olaparib significantly extended overall survival (OS), making it a preferred option.

Disinfectants induce oxidative damage in bacteria, but a single mutation triggers the expression of genes that help the ...

The innovation, he says, could transform the way scientists measure and address genomic breaks in gene-editing systems.

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...